Neoplasia/BPH

	Adjuvant therapy for renal cell carcinoma: lessons from past failures and new opportunities in the era of immune checkpoint inhibition. Front Immunol Liu Z, Cong X, Liu Z, Yin J, Chen C, Liu Z. PMID: 42125664 [PubMed - indexed for MEDLINE]
	Lipidomic Plasticity in Testicular Cancer Reflects Diagnostic Signatures in Tissue and Plasma: A Pilot Study. Andrology Nobre I, Ferreira HB, Domingues P, Guerra IMS, Pinho M, Melo T, Almeida RG, Sousa V, Quaresma V, da Silva ET, Oliveira PF, Paiva A, Domingues MR. PMID: 42124466 [PubMed - as supplied by publisher]
	The Prognostic Value of Tumor HER2 Expression in Predicting Oncological Outcomes of Patients with Advanced Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Int J Mol Sci Alibeiginejad MH, Esmaielpour A, Tsuboi I, Matsukawa A, Yanagisawa T, Mori K, Kardoust Parizi M. PMID: 42123709 [PubMed - indexed for MEDLINE]
	Genetic and Epigenetic Drivers of Wilms Tumor Predisposition in Russian Pediatric Patients: A Multicenter Study. Int J Mol Sci Semenova V, Sagoyan G, Zhukovskaya E, Kozlova V, Gegelia N, Mitrofanova A, Suleymanova A, Druy A, Zelenova E, Pavlov V, Rubanskay M, Karelin A, Varfolomeeva S, Nasedkina T. PMID: 42123644 [PubMed - indexed for MEDLINE]
	The Insulin-Urothelial Axis: Evaluating Insulin Resistance as a Convergent Driver of Bladder Cancer Across Diverse Risk Factor Profiles. Int J Mol Sci Tarantino G, Citro V, Imbimbo C, Crocetto F. PMID: 42123503 [PubMed - indexed for MEDLINE]
	Combined Robot-Assisted Radical Cystectomy and Robot-Assisted Nephroureterectomy for Synchronous High-Risk Upper Urinary Tract and Bladder Cancer: A Single-Center Retrospective Study and Review of the Literature. J Clin Med Kostakopoulos N, Evmorfopoulos K, Maresca G, Athanasiadis G, Kostakopoulos A, Dimitropoulos K. PMID: 42123144 [PubMed]
	Lifestyle Interventions in Patients in Active Surveillance for Prostate Cancer: A Systematic Review. J Clin Med Campetella M, Bizzarri FP, Russo P, Bientinesi R, Filomena GB, Sighinolfi MC, Rocco B, Sacco E. PMID: 42123101 [PubMed]
	Automated Prostate Cancer Detection on T2-Weighted MRI Using a Dual-Stream Attention Network: A Study on Private Saudi Clinical Data and Public Benchmark Datasets. J Clin Med Alqahtani S, Jowhari MA, Sabi YQ, Alshaari H. PMID: 42123060 [PubMed]
	The HGF/MET Axis in Advanced Prostate Cancer: From Context-Dependent Biology to Biomarker-Driven Therapeutic Strategies. Cancers (Basel) Koinis F, Vlachou MS, Nintos G, Christodoulopoulos G, Panagiotidis E, Eleftheropoulos I, Kallergi G, Samarinas M, Kotsakis A. PMID: 42122259 [PubMed]
	A FISH-Based Three-Tier Classification of Chromosome 3 Alterations in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications Utility. Cancers (Basel) Deng S, Ye T, Zhang L, Zhou L, Liu Y, Che Y, Dong L, Wang C, Yang X. PMID: 42122256 [PubMed]
	Kidney Cancer Trends, Risk Factors, and Interventions in American Indian and Alaska Native Populations: The Kidney Cancer Association Scientific Statement. Cancers (Basel) La Rosa S, Msaouel P, Sedgewick AJ, Maulding N, Recio-Boiles A, Carson WO, Haring RC, Batai K. PMID: 42122251 [PubMed]
	Rethinking Advanced Renal Cell Carcinoma: Integrative Genomics, Immunotherapy, and Molecular-Orthomolecular Strategies. Cancers (Basel) Tur, Krpina K, Trivanovi, Paveli, Kraljevi. PMID: 42122230 [PubMed]
	C-Reactive Protein/Albumin Ratio (CAR)-Integrated IMDC Model Improves Risk Stratification in Metastatic Renal Cell Carcinoma. Cancers (Basel) Ahdoot AI, Saitta C, Garofano G, Puri D, Meagher MF, Baker BH, Patil D, Tanaka H, Yasuda Y, Kobayashi M, Langbo WA, Agrawal L, Sabir W, Kashyap S, Karamcheti S, Vourganti S, Fukuda S, Fujii Y, Master V, Cherullo E, Liss MA, Musso G, Derweesh IH. PMID: 42122209 [PubMed]
	Refining Prognostic Stratification in Clear Cell Renal Cell Carcinoma: Genomic, Tissue-Based, Circulating Biomarkers and Integrated Models. Cancers (Basel) Chifu MB, Giu, Timofte AD, Costin CA, Rusu A, Ipatov AM, C. PMID: 42122167 [PubMed]
	Liquid Biopsy in Advanced Prostate Cancer. Cancers (Basel) Mediavilla-Medel P, García-Simón N, González-Del-Alba A, Romero A. PMID: 42122162 [PubMed]
	Artificial Intelligence-Enhanced Multiparametric MRI and VI-RADS in Bladder Cancer: Current Evidence, Clinical Opportunities and Barriers to Translation. Cancers (Basel) Popescu CG, Chipuc S, Zgura D, Haineala B, Zgura A. PMID: 42122119 [PubMed]
	Explainable Machine Learning-Based Overall Survival Classification in Prostate Adenocarcinoma Using Integrated Clinical and Transcriptomic Features. Diagnostics (Basel) Kurt HA, K, Çiçekliyurt MM. PMID: 42122046 [PubMed]
	Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma. Diagnostics (Basel) González-Padilla DA, Villacampa-Auba F, Caño-Velasco J, Subiela JD, Rodríguez M, Yánez C, Calva A, Talavera V, Muñoz C, Torres M, Barbas G, Andrés G, Sánchez-Zalabardo D, Guillén-Valderrama EF, Miñana-López B. PMID: 42122026 [PubMed]
	Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy. Diagnostics (Basel) Zattoni F, Mari A, Falagario UG, Bertolo RG, Albisinni S, Amparore D, Bianchi L, Campi R, Contieri R, De Lorenzis E, Dell'Oglio P, Marchioni M, Mollica V, Moschini M, Soria F, Talso M, Turri F, Pandolfo SD, Uronauti Group. PMID: 42122014 [PubMed]
	Sodium-glucose cotransporter 2 inhibitors and the risk of kidney cancer among patients with type 2 diabetes: a population-based cohort study. BMC Med Lee M, Lee H, Kim EJ, Son D, Lee HH, Kim HC, Kang ES. PMID: 42121200 [PubMed - as supplied by publisher]

Articles 1 - 20 / 187787

Page 1 of 9390



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy